<DOC>
	<DOCNO>NCT01579591</DOCNO>
	<brief_summary>This randomize , double-blind , placebo-controlled phase III study involve 160 patient design assess efficacy high potency probiotic preparation VSL # 3® versus placebo increase pathological major response rate patient undergoing concurrent CT pelvic RT .</brief_summary>
	<brief_title>VSL # 3 Versus Placebo Increasing Pathological Major Response Rate Patients With Rectal Cancer</brief_title>
	<detailed_description />
	<mesh_term>Rectal Neoplasms</mesh_term>
	<criteria>Age &gt; 18 year Ability sign inform consent understand nature placebo control trial . Ability complete questionnaire ( ) assistance . Life expectancy ≥ 6 month . Current diagnosis cancer support use continuous definitive adjuvant externalbeam RT pelvis minimum dose 4500 cGy deliver conventional multifield photon radiotherapy , 3D conformal photon radiotherapy intensity modulate photon therapy . Will receive concurrent administration chemotherapy ( 5FU , capecitabine , cisplatin , oxaliplatin , carboplatin , and/or mitomycin ) pelvic RT The following laboratory value obtain &gt; 28 day prior registration : Hemoglobin &gt; 10.0 g/dL WBC &gt; 3,500 Absolute neutrophil count &gt; 1,500 Platelets &gt; 100,000 ECOG Performance Status ( PS ) 0 , 1 2 Willing abstain ingestion yogurt product and/or product contain probiotic study drug treatment . Current prior metastasis beyond regional lymph node . Undergone abdominalperineal resection , Hartmann procedure , surgical procedure leave patient without function rectum . Known allergy probiotic preparation . Any history inflammatory bowel disease . &gt; grade 3 diarrhea , rectal bleeding , abdominal cramping , incontinence stool , ≤7 day prior registration . Any medical condition may interfere ability receive protocol treatment . Planned use leucovorin ( risk secretory diarrhea ) . Splitcourse RT plan . Prior pelvic RT . Proton RT . Any following : Pregnant woman Nursing woman Men woman childbearing potential unwilling employ adequate contraception Use probiotic ≤ 2 week prior registration . Use antibiotic ≤ 1 week prior registration . Planned continuous antibiotic treatment RT . History gastrointestinal genitourinary obstruction porphyria .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2012</verification_date>
</DOC>